PsychoGenics Inc. today announced that it has entered into an additional drug discovery agreement with Eli Lilly and Company (NYSE:LLY). Per the agreement, Lilly will supply pre-candidate compounds that PsychoGenics will evaluate using its proprietary drug discovery technologies, for the treatment of neuropsychiatric disorders. (PRWeb Jan 31, 2008)
Source: PRWeb: Medical Pharmaceuticals
Nature Made(R), America's number one-selling vitamin, mineral and supplement brand, in partnership with First magazine, announced today the launch of its “Your Heart: Feel the Beat” National Dance Contest. This nationwide contest encourages Americans to tango their way towards a better heart through dance. (PRWeb Jan 31, 2008)
Source: Medical Family Medicine
Visionary Medical Systems, Inc announced today that its DREAM Electronic Health Record (EHR) and CARE Disease Management solution has been chosen by HopeHealth, a South Carolina Federally Qualified Health Center (FQHC) and a member of Community Integrated Management Solutions, LLC, an Independent Practice Association (IPA) formed by South Carolina FQHCs. (PRWeb Jan 31, 2008)
Source: Medical Family Medicine
Baxa announces the launch of its new corporate Web site with enhanced user features and technical content. The site provides a global platform for information exchange, product marketing, public relations, and sales and technical support for health-system pharmacists and nurses, as well as pharmaceutical industry representatives. (PRWeb Jan 31, 2008)
Source: PRWeb: Medical Pharmaceuticals
De Angelis Freelance Science announces the start of operations as an international consulting company providing outstanding scientific/technical writing, editing, and consulting services to scientific, biomedical, technological and pharmaceutical communities worldwide. (PRWeb Jan 31, 2008)
Source: PRWeb: Medical Pharmaceuticals
RPh on the Go on Monday proudly announced a completely redesigned online presence that provides greater flexibility and gives more people easier access to information and resources. (PRWeb Jan 31, 2008)
Source: PRWeb: Medical Pharmaceuticals
LawScribe, Inc, one of the worlds's leading Legal Process Outsourcing (LPO) companies, and Iqwest, the global leader in the provision of award winning, cutting edge document indexing, organizing and analysis technologies, announced today an exclusive partnership aimed at providing law firms and legal departments a one-stop solution for the most advanced and cost-effective document review available. (PRWeb Jan 31, 2008)
Source: PRWeb: Medical Pharmaceuticals
eDrugstore, a leading U.S. online pharmacy serving the U.S. and Canada, has just redesigned and enhanced their Internet drug store to significantly improve navigation, content, and design. With a totally fresh appearance and format, eDrugstore.net provides drugstore discounts and coupons, health information, and drug news for online shoppers. (PRWeb Jan 31, 2008)
Source: PRWeb: Medical Pharmaceuticals
M's Science Corporation (MSC), a clinical stage discovery and development company announced today that it initiated a Phase 2 study in Europe with its lead product SA4503 for treatment of stroke. Earlier this year, MSC announced the initiation of a Phase 2 trial with SA4503 for the treatment of major depression. (PRWeb Jan 30, 2008)
Source: PRWeb: Medical Pharmaceuticals
Inovio Biomedical Corp. (AMEX:INO), a leader in enabling the development of therapeutic DNA vaccines for cancers and infectious diseases using its electroporation-based delivery platform, announced today the online availability of a peer-reviewed scientific paper, “DNA vaccines: precision tools for activating effective immunity against cancer”, in the February 2008 issue of Nature Reviews Cancer. The paper is authored by Jason Rice, Christian H. Ottensmeier and Freda K. Stevenson of the University of Southampton (UK). Dr. Ottensmeier and Dr. Stevenson are investigators for a prostate cancer Phase I/II clinical study assessing a DNA vaccine delivered using Inovio's electroporation-based DNA delivery technology, which is intended to enable and enhance the potency of DNA vaccines. (PRWeb Jan 30, 2008)
Source: PRWeb: Medical Pharmaceuticals
